Silo Pharma, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
1.13M
on 2026-06-30, from 189K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-15 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
13 of its filings are not read yet.
Warrants
2,269
Warrants of every class as tagged in the XBRL facts on 2025-12-31. Adjusted for the 1-for-15 reverse split. 10-K ↗
Cash
6.3 quarters
$5.2M on 2026-06-30 ÷ $835K a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-07-09 | Private placement incl. 0.50M pre-funded | 991,930 | $6.452 | not stated | 8-K ↗ |
| 2026-04-15 | Public offering | not read | $0.60 | not read | 424B3 ↗ |
Also on file: a 1-for-15 reverse split, 2026-06-01 8-K ↗